Andrew D. Dickinson
2021
Compensation breakdown
| Non-Equity Incentive Plan | $1,558,751 |
|---|---|
| Option Awards | $1,049,984 |
| Salary | $973,567 |
| Stock Awards | $2,862,493 |
| Other | $15,000 |
| Total | $6,459,795 |
Dickinson received $2.9M in stock awards, accounting for 44% of the total pay in 2021.
Dickinson also received $1.6M in non-equity incentive plan, $1M in option awards, $973.6K in salary and $15K in other compensation.
Rankings
In 2021, Andrew D. Dickinson's compensation ranked 1,956th out of 12,415 executives tracked by ExecPay. In other words, Dickinson earned more than 84.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,956 out of 12,415 | 84th |
Division Manufacturing | 740 out of 5,505 | 87th |
Major group Chemicals And Allied Products | 286 out of 2,375 | 88th |
Industry group Drugs | 245 out of 2,096 | 88th |
Industry Biological Products, Except Diagnostic Substances | 74 out of 449 | 84th |
Pay ratio
| Andrew D. Dickinson's Pay | $6,459,795 |
|---|---|
| Median Employee's Pay | $211,687 |
| Pay Ratio | 31to 1 |
In 2021, the annual total compensation of Andrew D. Dickinson was $6,459,795.
The annual total compensation of the median employee at Gilead Sciences was $211,687.
The ratio of Andrew D. Dickinson's pay to the pay of median employee was therefore 31 to one.
Dickinson's colleagues
We found four more compensation records of executives who worked with Andrew D. Dickinson at Gilead Sciences in 2021.